Matches in Wikidata for { <http://www.wikidata.org/entity/Q64395234> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q64395234 description "assaig clínic" @default.
- Q64395234 description "clinical trial" @default.
- Q64395234 description "clinical trial" @default.
- Q64395234 description "clinical trial" @default.
- Q64395234 description "clinical trial" @default.
- Q64395234 description "ensaio clínico" @default.
- Q64395234 description "ensayo clínico" @default.
- Q64395234 description "ensayu clínicu" @default.
- Q64395234 description "essai clinique" @default.
- Q64395234 description "klinisch onderzoek" @default.
- Q64395234 description "клінічне випробування" @default.
- Q64395234 description "կլինիկական փորձարկում" @default.
- Q64395234 name "A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis." @default.
- Q64395234 type Item @default.
- Q64395234 label "A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis." @default.
- Q64395234 prefLabel "A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis." @default.
- Q64395234 P1050 Q64395234-26FDF525-B063-43BD-BE33-AD7177BC4FE9 @default.
- Q64395234 P1050 Q64395234-9CD3176D-1619-4ED3-A552-762D4C797887 @default.
- Q64395234 P1132 Q64395234-06A4D50C-B3A9-47D0-AB3B-4C495A650D49 @default.
- Q64395234 P1476 Q64395234-02BA5485-6D03-46A2-AFF2-37B082FBCF60 @default.
- Q64395234 P17 Q64395234-291C41DE-85E2-4F21-A875-A5375270452B @default.
- Q64395234 P1813 Q64395234-4C156223-E3BF-4973-A593-98426DD763F5 @default.
- Q64395234 P3098 Q64395234-51A59391-610B-42EB-9B08-D8B3027A2936 @default.
- Q64395234 P31 Q64395234-D2FC0BF0-6329-4465-BE8A-98BAAEB57451 @default.
- Q64395234 P580 Q64395234-E855E040-3882-4AF9-8EA7-567E09AFA1FC @default.
- Q64395234 P582 Q64395234-22B261FD-BDAF-4B16-AC0B-22E975836670 @default.
- Q64395234 P6099 Q64395234-8F40593F-2050-4BBA-8634-B53B059DEAC3 @default.
- Q64395234 P6153 Q64395234-E3A780F6-BC99-423F-9B5A-05A409F6F340 @default.
- Q64395234 P6153 Q64395234-EBB6BD12-B783-4099-98C8-B8259F36D332 @default.
- Q64395234 P8363 Q64395234-85DA3DB5-5A52-40A3-B37B-B2267AC8EAC4 @default.
- Q64395234 P1050 Q179945 @default.
- Q64395234 P1050 Q2051832 @default.
- Q64395234 P1132 "+221" @default.
- Q64395234 P1476 "A Phase 4, Multicenter, Randomized, Placebo-controlled, Double-blind, Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate Plaque Psoriasis" @default.
- Q64395234 P17 Q30 @default.
- Q64395234 P1813 "UNVEIL" @default.
- Q64395234 P3098 "NCT02425826" @default.
- Q64395234 P31 Q30612 @default.
- Q64395234 P580 "2015-04-20T00:00:00Z" @default.
- Q64395234 P582 "2016-02-12T00:00:00Z" @default.
- Q64395234 P6099 Q42825046 @default.
- Q64395234 P6153 Q153265 @default.
- Q64395234 P6153 Q30270365 @default.
- Q64395234 P8363 Q78089383 @default.